Merck · 1 day ago
2026 Future Talent Program - Bioinformatics Intern
Cambridge, MA
Internship
Hybrid
Intern
$40K/yr - $106K/yrMerck is a leading company in the pharmaceutical industry, and they are seeking a highly motivated intern to join their Bioinformatics Team in Data Science & Scientific Informatics. The intern will evaluate, develop, and optimize computational methods to analyze next-generation sequencing datasets in support of drug discovery and development programs.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Evaluate, develop, and optimize computational methods to analyze next-generation sequencing datasets
Produce bioinformatics pipelines that can be operated on high-performance computing clusters and in the cloud
Collaborate with biologists and data analysts in various therapeutic areas
Qualification
Required
Applicants should pursuing a master's degree or doctorate in computational biology, bioinformatics, or a related field. Exceptional undergraduate candidates who can demonstrate strong technical capabilities are also encouraged to apply
Experience analyzing next-generation sequencing datasets, such as WGS, WES, RNA-seq, ChIP-seq, ATAC-seq, and single-cell applications
Experience with a pipeline scripting language such as Nextflow
Experience evaluating methods for common bioinformatics applications, such as alignment, assembly, variant detection, genome enrichment, and phylogenetics
Familiarity with common bioinformatics file formats (FASTA, FASTQ, BAM, VCF, etc.)
Proficiency in programming languages (e.g., Python, R, C++) in a Unix/Linux environment
Experience with high-performance Linux clusters and cloud computing
Experience leveraging online resources (software manuals, GitHub, Stack Overflow) to troubleshoot
Excellent interpersonal and team skills
Excellent verbal and written communication skills in English
Preferred
Excellent verbal and written communication skills in English
Experience in applying and optimizing machine learning tools
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Founded in 1891
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital Advisors"Gavi, the Vaccine Alliance"
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Betty Larson
Executive Vice President and Chief Human Resources Officer
Dean Li
Executive Vice President and President, Merck Research Laboratories
Recent News
2026-02-05
Genetic Engineering News
2026-02-05
Company data provided by crunchbase